NASDAQ:ABAX - Abaxis Stock Price, Price Target & More

$70.86 -1.58 (-2.18 %)
(As of 04/25/2018 04:00 PM ET)
Previous Close$70.86
Today's Range$69.6650 - $72.22
52-Week Range$43.66 - $78.53
Volume151,306 shs
Average Volume195,704 shs
Market Capitalization$1.65 billion
P/E Ratio55.80
Dividend Yield0.88%
Beta1.16

About Abaxis (NASDAQ:ABAX)

Abaxis logoAbaxis, Inc. develops, manufactures, markets, and sells portable blood analysis systems for use in human or veterinary patient care settings to provide rapid blood constituent measurements for clinicians worldwide. It operates in two segments, Medical Market and Veterinary Market. The company offers Piccolo chemistry analyzers with rapid blood constituent measurements for use in human patient care; and Piccolo profiles that are single-use medical reagents. It also provides VetScan VS2, a chemistry, electrolyte, immunoassay, and blood gas analyzer delivering results from a sample of whole blood, serum, or plasma; VetScan profiles, which are packaged as single-use plastic veterinary reagent discs; and VetScan HM5, VetScan HM2, VetScan HMII, and VetScan HMT hematology instruments, as well as reagent kits for veterinary applications. In addition, the company offers VetScan VSpro that assists the diagnosis and evaluation of suspected bleeding disorders, toxicity/poisoning, disseminated intravascular coagulation evaluation, hepatic disease, monitoring therapy, and disease progression states; VetScan VSpro coagulation test to evaluate prothrombin and the activated partial thromboplastin times; VetScan VSpro fibrinogen test for in-vitro determination of fibrinogen levels in equine platelet poor plasma from a citrated stabilized whole blood sample; and i-STAT that delivers blood gas, electrolyte, chemistry, and hematology results. Further, it provides VetScan rapid tests for the detection of various diseases, as well as sells products developed through its patented Orbos discrete lyophilization process to companies for other applications. The company sells its products through direct sales force and independent distributors. Abaxis, Inc. was founded in 1989 and is headquartered in Union City, California.

Receive ABAX News and Ratings via Email

Sign-up to receive the latest news and ratings for ABAX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:ABAX
CUSIP00256710
Phone510-675-6500

Debt

Debt-to-Equity RatioN/A
Current Ratio5.92%
Quick Ratio4.92%

Price-To-Earnings

Trailing P/E Ratio55.80
Forward P/E Ratio61.09
P/E Growth9.85

Sales & Book Value

Annual Sales$227.22 million
Price / Sales7.08
Cash Flow$1.6032 per share
Price / Cash44.20
Book Value$11.81 per share
Price / Book6.00

Profitability

EPS (Most Recent Fiscal Year)$1.27
Net Income$32.71 million
Net Margins10.51%
Return on Equity10.09%
Return on Assets8.69%

Miscellaneous

Employees584
Outstanding Shares22,700,000

How to Become a New Pot Stock Millionaire

Abaxis (NASDAQ:ABAX) Frequently Asked Questions

What is Abaxis' stock symbol?

Abaxis trades on the NASDAQ under the ticker symbol "ABAX."

How often does Abaxis pay dividends? What is the dividend yield for Abaxis?

Abaxis announced a quarterly dividend on Thursday, January 25th. Investors of record on Thursday, March 1st will be paid a dividend of $0.16 per share on Thursday, March 15th. This represents a $0.64 annualized dividend and a dividend yield of 0.90%. The ex-dividend date of this dividend is Wednesday, February 28th. View Abaxis' Dividend History.

How will Abaxis' stock buyback program work?

Abaxis announced that its board has approved a share repurchase program on Wednesday, October 25th 2017, which allows the company to repurchase $21,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's board believes its shares are undervalued.

How were Abaxis' earnings last quarter?

Abaxis (NASDAQ:ABAX) issued its quarterly earnings results on Thursday, January, 25th. The medical research company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.05. The medical research company earned $59.70 million during the quarter, compared to analysts' expectations of $59.37 million. Abaxis had a net margin of 10.51% and a return on equity of 10.09%. The firm's quarterly revenue was up 13.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.30 EPS. View Abaxis' Earnings History.

When is Abaxis' next earnings date?

Abaxis is scheduled to release their next quarterly earnings announcement on Thursday, April, 26th 2018. View Earnings Estimates for Abaxis.

What price target have analysts set for ABAX?

7 equities research analysts have issued twelve-month price objectives for Abaxis' stock. Their forecasts range from $48.00 to $65.00. On average, they expect Abaxis' share price to reach $56.6250 in the next year. View Analyst Ratings for Abaxis.

Who are some of Abaxis' key competitors?

Who are Abaxis' key executives?

Abaxis' management team includes the folowing people:
  • Mr. Clinton H. Severson, Chairman & CEO (Age 70)
  • Mr. Donald P. Wood, Pres & COO (Age 66)
  • Mr. Ross Taylor Jr., CFO, Principal Accounting Officer, VP of Fin. & Sec. (Age 55)
  • Dr. Kenneth P. Aron Ph.D., Chief Technology Officer (Age 65)
  • Dr. Craig M. Tockman DVM, VP of Animal Health Sales and Marketing - North America (Age 58)

Has Abaxis been receiving favorable news coverage?

News stories about ABAX stock have been trending positive on Wednesday, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Abaxis earned a coverage optimism score of 0.42 on Accern's scale. They also gave headlines about the medical research company an impact score of 43.95 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Abaxis' major shareholders?

Abaxis' stock is owned by many different of institutional and retail investors. Top institutional investors include PRIMECAP MANAGEMENT COMPANY (9.77%). Company insiders that own Abaxis stock include Achim Henkel, Clinton Severson, Craig Tockman, Donald Peter Wood, Henk Evenhuis, Kenneth Aron, Michael D Casey, Prithipal Singh and Richard Bastiani. View Institutional Ownership Trends for Abaxis.

How do I buy shares of Abaxis?

Shares of ABAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Abaxis' stock price today?

One share of ABAX stock can currently be purchased for approximately $70.86.

How big of a company is Abaxis?

Abaxis has a market capitalization of $1.65 billion and generates $227.22 million in revenue each year. The medical research company earns $32.71 million in net income (profit) each year or $1.27 on an earnings per share basis. Abaxis employs 584 workers across the globe.

How can I contact Abaxis?

Abaxis' mailing address is 3240 WHIPPLE ROAD, UNION CITY CA, 94587. The medical research company can be reached via phone at 510-675-6500 or via email at [email protected]


MarketBeat Community Rating for Abaxis (ABAX)

Community Ranking:  1.8 out of 5 (star)
Outperform Votes:  160 (Vote Outperform)
Underperform Votes:  286 (Vote Underperform)
Total Votes:  446
MarketBeat's community ratings are surveys of what our community members think about Abaxis and other stocks. Vote "Outperform" if you believe ABAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ABAX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Abaxis (NASDAQ:ABAX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Abaxis in the last 12 months. Their average twelve-month price target is $56.6250, suggesting that the stock has a possible downside of 20.09%. The high price target for ABAX is $65.00 and the low price target for ABAX is $48.00. There are currently 1 sell rating, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.132.00
Ratings Breakdown: 1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $56.6250$56.6250$49.6250$47.6250
Price Target Upside: 20.09% downside11.79% downside20.52% downside3.44% downside

Abaxis (NASDAQ:ABAX) Consensus Price Target History

Price Target History for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/8/2018Bank of AmericaBoost Price TargetUnderperform -> Sell$46.00 -> $48.00MediumView Rating Details
1/29/2018Canaccord GenuityReiterated RatingHold$65.00LowView Rating Details
1/26/2018Stifel NicolausBoost Price TargetHold -> Hold$48.00 -> $57.00HighView Rating Details
1/9/2018UBSUpgradeUnderperform -> Market PerformMediumView Rating Details
1/9/2018Raymond JamesUpgradeUnderperform -> Market PerformMediumView Rating Details
1/5/2018Northcoast ResearchUpgradeNeutral -> BuyHighView Rating Details
12/1/2017AegisReiterated RatingHoldHighView Rating Details
2/1/2017Seaport Global SecuritiesUpgradeBuyN/AView Rating Details
8/16/2016Credit Suisse GroupReiterated RatingSell$39.00N/AView Rating Details
7/22/2016Feltl & Co.DowngradeHold -> SellN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Abaxis (NASDAQ:ABAX) Earnings History and Estimates Chart

Earnings by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Earnings Estimates

2018 EPS Consensus Estimate: $1.35
2019 EPS Consensus Estimate: $1.58
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.33$0.33$0.33
Q2 20181$0.38$0.38$0.38
Q3 20181$0.30$0.30$0.30
Q4 20181$0.34$0.34$0.34
Q1 20191$0.40$0.40$0.40
Q2 20191$0.42$0.42$0.42
Q3 20191$0.33$0.33$0.33
Q4 20191$0.43$0.43$0.43

Abaxis (NASDAQ ABAX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018$0.31N/AView Earnings Details
1/25/2018Q3 2018$0.26$0.31$59.37 million$59.70 millionViewListenView Earnings Details
10/24/2017Q2 2018$0.27$0.29$60.85 million$58.90 millionViewN/AView Earnings Details
7/27/2017Q1 2018$0.33$0.28$60.37 million$58.26 millionViewN/AView Earnings Details
4/27/2017Q4 2017$0.3340$0.33$58.04 million$58.20 millionViewN/AView Earnings Details
1/26/2017Q317$0.31$0.30$54.36 million$52.80 millionViewN/AView Earnings Details
10/25/2016Q217$0.35$0.34$60.69 million$58.60 millionViewListenView Earnings Details
7/21/2016Q117$0.32$0.30$58.70 million$57.70 millionViewListenView Earnings Details
4/28/2016Q416$0.32$0.36$56.62 million$57.00 millionViewListenView Earnings Details
1/28/2016Q316$0.33$0.35$58.52 million$52.90 millionViewListenView Earnings Details
10/27/2015Q216$0.32$0.34$56.20 million$56.00 millionViewListenView Earnings Details
7/23/2015Q116$0.28$0.31$53.75 million$53.10 millionViewListenView Earnings Details
4/30/2015Q415$0.27$0.17$55.62 million$52.00 millionViewN/AView Earnings Details
1/29/2015Q315$0.25$0.26$51.70 million$59.50 millionViewN/AView Earnings Details
10/21/2014Q215$0.23$0.24$50.55 million$53.90 millionViewListenView Earnings Details
7/24/2014Q115$0.19$0.21$46.95 million$47.50 millionViewN/AView Earnings Details
4/24/2014Q414$0.19$0.17$45.74 million$42.04 millionViewN/AView Earnings Details
1/31/2014Q314$0.20$0.14$49.47 million$40.00 millionViewN/AView Earnings Details
10/22/2013Q114$0.21$0.18$48.60 million$45.90 millionViewN/AView Earnings Details
7/25/2013Q1 2014$0.23$0.14$49.13 million$43.20 millionViewListenView Earnings Details
4/25/2013Q4 2013$0.26$0.30$52.47 million$50.00 millionViewListenView Earnings Details
1/31/2013Q3 2013$0.20$0.22$45.75 million$49.80 millionViewListenView Earnings Details
10/23/2012$0.18$0.18ViewN/AView Earnings Details
7/26/2012$0.17$0.13ViewN/AView Earnings Details
4/26/2012$0.16$0.21ViewN/AView Earnings Details
1/26/2012$0.16$0.13ViewN/AView Earnings Details
10/25/2011$0.14$0.15ViewN/AView Earnings Details
7/28/2011$0.16$0.10ViewN/AView Earnings Details
4/28/2011$0.16$0.15ViewN/AView Earnings Details
1/27/2011$0.18$0.17ViewN/AView Earnings Details
10/26/2010Q2 2011$0.17$0.17ViewN/AView Earnings Details
7/29/2010Q1 2011$0.16$0.16ViewN/AView Earnings Details
4/29/2010Q4 2010$0.17$0.12ViewN/AView Earnings Details
1/28/2010Q3 2010$0.17$0.15ViewN/AView Earnings Details
10/27/2009Q2 2010$0.17$0.14ViewN/AView Earnings Details
7/30/2009Q1 2010$0.14$0.17ViewN/AView Earnings Details
4/29/2009Q4 2009$0.17$0.12ViewN/AView Earnings Details
1/29/2009Q3 2009$0.16$0.15ViewN/AView Earnings Details
10/27/2008Q2 2009$0.16$0.15ViewN/AView Earnings Details
7/24/2008Q1 2009$0.16$0.12ViewN/AView Earnings Details
5/1/2008Q4 2008$0.16$0.15ViewN/AView Earnings Details
1/31/2008Q3 2008$0.16$0.14ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Abaxis (NASDAQ:ABAX) Dividend Information

Abaxis pays an annual dividend of $0.64 per share, with a dividend yield of 0.90%. ABAX's most recent quarterly dividend payment was Thursday, March 15. Abaxis pays out 50.39% of its earnings out as a dividend.
Most Recent Dividend:3/15/2018
Annual Dividend:$0.64
Dividend Yield:0.90%
Payout Ratio:50.39% (Trailing 12 Months of Earnings)
55.17% (Based on This Year's Estimates)
43.84% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ:ABAX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
1/25/2018quarterly$0.160.91%2/28/20183/1/20183/15/2018
10/24/2017quarterly$0.161.28%11/30/201712/1/201712/15/2017
7/27/2017quarterly$0.141.19%8/30/20179/1/20179/15/2017
4/27/2017quarterly$0.141.24%5/30/20176/1/20176/15/2017
1/26/2017quarterly$0.141.13%2/27/20173/1/20173/15/2017
10/28/2016quarterly$0.141.17%11/29/201612/1/201612/15/2016
7/21/2016quarterly$0.121.04%8/30/20169/1/20169/15/2016
4/28/2016quarterly$0.121.06%6/1/20166/3/20166/17/2016
1/28/2016quarterly$0.111.01%3/1/20163/3/20163/17/2016
11/3/2015quarterly$0.110.84%12/1/201512/3/201512/17/2015
7/23/2015quarterly$0.110.9%9/1/20159/3/20159/17/2015
4/30/2015quarterly$0.110.79%6/2/20156/4/20156/18/2015
1/30/2015quarterly$0.100.65%2/27/20153/3/20153/17/2015
10/23/2014quarterly$0.100.82%11/13/201411/17/201412/16/2014
7/24/2014quarterly$0.100.86%8/29/20149/3/20149/17/2014
4/24/2014quarterly$0.105/30/20146/3/20146/17/2014
12/6/2012special$1.0012/13/201212/17/201212/28/2012
(Data available from 1/1/2013 forward)

Insider Trades

Abaxis (NASDAQ ABAX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 4.30%
Institutional Ownership Percentage: 99.66%
Insider Trading History for Abaxis (NASDAQ:ABAX)
Institutional Ownership by Quarter for Abaxis (NASDAQ:ABAX)

Abaxis (NASDAQ ABAX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/8/2018Michael D CaseyDirectorSell5,000$71.07$355,350.0027,290View SEC Filing  
3/6/2018Donald Peter WoodCOOSell10,000$68.99$689,900.00View SEC Filing  
3/6/2018Kenneth AronInsiderSell1,412$69.59$98,261.08View SEC Filing  
3/6/2018Prithipal SinghDirectorSell2,000$70.25$140,500.00View SEC Filing  
2/27/2018Achim HenkelInsiderSell3,600$69.08$248,688.0057,650View SEC Filing  
1/31/2018Craig TockmanVPSell1,650$74.33$122,644.5010,866View SEC Filing  
1/31/2018Prithipal SinghDirectorSell2,000$74.63$149,260.0044,000View SEC Filing  
5/26/2017Achim HenkelInsiderSell650$48.87$31,765.5058,950View SEC Filing  
5/8/2017Achim HenkelDirectorSell8,650$47.75$413,037.5068,150View SEC Filing  
2/2/2017Richard BastianiDirectorSell4,000$51.12$204,480.0049,178View SEC Filing  
12/6/2016Clinton SeversonCEOSell15,000$51.35$770,250.00562,300View SEC Filing  
12/2/2016Kenneth AronInsiderSell5,000$51.09$255,450.0092,151View SEC Filing  
9/9/2016Clinton SeversonCEOSell2,000$48.29$96,580.00574,691View SEC Filing  
9/8/2016Prithipal SinghDirectorSell1,000$49.50$49,500.0042,500View SEC Filing  
8/25/2016Prithipal SinghDirectorSell1,500$50.30$75,450.0043,500View SEC Filing  
8/24/2016Donald Peter WoodInsiderSell8,500$50.21$426,785.0052,618View SEC Filing  
6/9/2016Richard BastianiDirectorSell5,000$46.75$233,750.0054,400View SEC Filing  
5/17/2016Achim HenkelDirectorSell5,000$44.43$222,150.0053,609View SEC Filing  
5/9/2016Henk EvenhuisDirectorSell3,000$45.00$135,000.0015,400View SEC Filing  
2/9/2016Vernon E AltmanDirectorBuy303$39.87$12,080.6116,303View SEC Filing  
12/8/2015Craig TockmanVPSell560$54.44$30,486.401,189View SEC Filing  
2/9/2015Prithipal SinghDirectorSell2,500$60.50$151,250.00View SEC Filing  
12/8/2014Kenneth AronCTOSell2,000$56.68$113,360.00View SEC Filing  
11/25/2014Clinton SeversonCEOSell2,286$56.00$128,016.00View SEC Filing  
11/13/2014Clinton SeversonCEOSell10,000$55.00$550,000.00View SEC Filing  
11/5/2014Clinton SeversonCEOSell10,000$54.00$540,000.00View SEC Filing  
11/3/2014Alberto Santa InesCFOSell1,652$53.09$87,704.68View SEC Filing  
11/3/2014Clinton SeversonCEOSell5,000$53.00$265,000.00View SEC Filing  
10/31/2014Clinton SeversonCEOSell10,000$51.50$515,000.00View SEC Filing  
8/12/2014Richard BastianiDirectorSell1,000$45.40$45,400.00View SEC Filing  
7/30/2014Alberto Santa InesCFOSell10,738$47.81$513,383.78View SEC Filing  
7/29/2014Alberto Santa InesCFOSell17,293$48.01$830,236.93View SEC Filing  
6/5/2014Richard BastianiDirectorSell2,000$42.10$84,200.00View SEC Filing  
6/3/2014Richard BastianiDirectorSell4,000$41.88$167,520.00View SEC Filing  
5/22/2014Achim HenkelDirectorSell8,500$41.63$353,855.00View SEC Filing  
5/14/2014Henk EvenhuisDirectorSell4,000$44.06$176,240.0010,400View SEC Filing  
5/1/2014Henk EvenhuisDirectorSell4,500$41.00$184,500.0014,400View SEC Filing  
3/4/2014Vladimir OstoichVPSell9,800$38.53$377,594.00381,987View SEC Filing  
2/24/2014Kenneth AronCTOSell1,000$38.98$38,980.0064,330View SEC Filing  
2/13/2014Donald Peter WoodCOOSell8,864$38.50$341,264.0020,634View SEC Filing  
6/7/2013Clinton SeversonCEOSell10,000$44.50$445,000.00View SEC Filing  
6/7/2013Martin MulroyInsiderSell14,000$44.80$627,200.00View SEC Filing  
5/22/2013Kenneth AronCTOSell4,200$43.28$181,776.00View SEC Filing  
5/7/2013Achim HenkelDirectorSell5,000$44.07$220,350.00View SEC Filing  
3/1/2013Achim HenkelDirectorSell1,000$42.85$42,850.00View SEC Filing  
2/26/2013Martin MulroyInsiderSell12,000$41.84$502,080.00View SEC Filing  
2/5/2013Kenneth AronCTOSell40,000$44.13$1,765,200.00View SEC Filing  
2/4/2013Martin MulroyInsiderSell12,000$43.97$527,640.00View SEC Filing  
11/23/2012Richard BastianiDirectorSell5,000$36.60$183,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Abaxis (NASDAQ ABAX) News Headlines

Source:
DateHeadline
Head-To-Head Comparison: Abaxis (ABAX) versus Cubic (CUB)Head-To-Head Comparison: Abaxis (ABAX) versus Cubic (CUB)
www.americanbankingnews.com - April 25 at 7:18 PM
LabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 ViewLabCorp (LH) Beats on Q1 Earnings, Revenues, Lifts '18 View
finance.yahoo.com - April 25 at 4:41 PM
Abaxis To Report Fourth Quarter And Fiscal Year 2018 Financial Results On Thursday, April 26, 2018Abaxis To Report Fourth Quarter And Fiscal Year 2018 Financial Results On Thursday, April 26, 2018
finance.yahoo.com - April 20 at 9:34 AM
$67.03 Million in Sales Expected for Abaxis (ABAX) This Quarter$67.03 Million in Sales Expected for Abaxis (ABAX) This Quarter
www.americanbankingnews.com - April 19 at 4:27 AM
Abbott (ABT) Q1 Earnings & Revenues Top, '18 View RetainedAbbott (ABT) Q1 Earnings & Revenues Top, '18 View Retained
finance.yahoo.com - April 18 at 4:48 PM
Abaxis (ABAX) to Release Earnings on WednesdayAbaxis (ABAX) to Release Earnings on Wednesday
www.americanbankingnews.com - April 18 at 1:52 AM
$0.32 Earnings Per Share Expected for Abaxis (ABAX) This Quarter$0.32 Earnings Per Share Expected for Abaxis (ABAX) This Quarter
www.americanbankingnews.com - April 17 at 8:00 AM
Abaxis (ABAX) Downgraded by Zacks Investment Research to "Sell"Abaxis (ABAX) Downgraded by Zacks Investment Research to "Sell"
www.americanbankingnews.com - April 15 at 8:37 AM
Abaxis (ABAX) Downgraded by BidaskClub to "Buy"Abaxis (ABAX) Downgraded by BidaskClub to "Buy"
www.americanbankingnews.com - April 13 at 5:29 PM
Here's Why You Should Steer Clear of AmerisourceBergen NowHere's Why You Should Steer Clear of AmerisourceBergen Now
finance.yahoo.com - April 13 at 4:33 PM
Abaxis Inc (ABAX) Given Average Rating of "Hold" by AnalystsAbaxis Inc (ABAX) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - April 11 at 9:19 PM
Here's Why You Should Hold on to Varian Medical Stock NowHere's Why You Should Hold on to Varian Medical Stock Now
finance.yahoo.com - April 10 at 9:47 AM
Abaxis (ABAX) PT Lowered to $39.00 at Bank of AmericaAbaxis (ABAX) PT Lowered to $39.00 at Bank of America
www.americanbankingnews.com - April 5 at 12:39 PM
Abaxis (ABAX) Downgraded by Zacks Investment ResearchAbaxis (ABAX) Downgraded by Zacks Investment Research
www.americanbankingnews.com - April 4 at 7:58 PM
Abaxis (ABAX) Upgraded at ValuEngineAbaxis (ABAX) Upgraded at ValuEngine
www.americanbankingnews.com - April 3 at 8:12 PM
Abaxis (ABAX) Upgraded by Zacks Investment Research to "Strong-Buy"Abaxis (ABAX) Upgraded by Zacks Investment Research to "Strong-Buy"
www.americanbankingnews.com - April 3 at 2:59 PM
$67.03 Million in Sales Expected for Abaxis Inc (ABAX) This Quarter$67.03 Million in Sales Expected for Abaxis Inc (ABAX) This Quarter
www.americanbankingnews.com - April 2 at 4:00 AM
 Brokerages Anticipate Abaxis Inc (ABAX) Will Announce Earnings of $0.32 Per Share Brokerages Anticipate Abaxis Inc (ABAX) Will Announce Earnings of $0.32 Per Share
www.americanbankingnews.com - March 31 at 9:46 AM
Abaxis (ABAX) Upgraded at Raymond James FinancialAbaxis (ABAX) Upgraded at Raymond James Financial
www.americanbankingnews.com - March 29 at 11:52 PM
Abaxis (ABAX) Upgraded by UBS to Market PerformAbaxis (ABAX) Upgraded by UBS to Market Perform
www.americanbankingnews.com - March 29 at 11:18 PM
Canaccord Genuity Reiterates Hold Rating for Abaxis (ABAX)Canaccord Genuity Reiterates Hold Rating for Abaxis (ABAX)
www.americanbankingnews.com - March 28 at 12:58 PM
Abaxis (ABAX) Upgraded to "Hold" by BidaskClubAbaxis (ABAX) Upgraded to "Hold" by BidaskClub
www.americanbankingnews.com - March 26 at 3:13 PM
Abaxis Inc (ABAX) Receives Consensus Recommendation of "Hold" from BrokeragesAbaxis Inc (ABAX) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - March 17 at 9:28 PM
Head to Head Comparison: Amedica (AMDA) and Abaxis (ABAX)Head to Head Comparison: Amedica (AMDA) and Abaxis (ABAX)
www.americanbankingnews.com - March 17 at 5:20 AM
Abaxis Inc Expected to Post Q3 2019 Earnings of $0.33 Per Share (ABAX)Abaxis Inc Expected to Post Q3 2019 Earnings of $0.33 Per Share (ABAX)
www.americanbankingnews.com - March 16 at 1:56 PM
Northcoast Research Equities Analysts Boost Earnings Estimates for Abaxis Inc (ABAX)Northcoast Research Equities Analysts Boost Earnings Estimates for Abaxis Inc (ABAX)
www.americanbankingnews.com - March 15 at 9:40 AM
Form 4 ABAXIS INC For: Mar 08 Filed by: CASEY MICHAEL DForm 4 ABAXIS INC For: Mar 08 Filed by: CASEY MICHAEL D
www.streetinsider.com - March 12 at 11:08 AM
Abaxis (ABAX) and Varian Medical Systems (VAR) Critical ComparisonAbaxis (ABAX) and Varian Medical Systems (VAR) Critical Comparison
www.americanbankingnews.com - March 11 at 10:34 PM
Insider Selling: Abaxis Inc (ABAX) Director Sells 5,000 Shares of StockInsider Selling: Abaxis Inc (ABAX) Director Sells 5,000 Shares of Stock
www.americanbankingnews.com - March 9 at 9:28 PM
See what the IHS Markit Score report has to say about Abaxis Inc.See what the IHS Markit Score report has to say about Abaxis Inc.
finance.yahoo.com - March 9 at 9:53 AM
Insider Selling: Abaxis Inc (ABAX) Director Sells 2,000 Shares of StockInsider Selling: Abaxis Inc (ABAX) Director Sells 2,000 Shares of Stock
www.americanbankingnews.com - March 8 at 7:07 PM
Abaxis Inc (ABAX) Insider Kenneth Aron Sells 1,412 SharesAbaxis Inc (ABAX) Insider Kenneth Aron Sells 1,412 Shares
www.americanbankingnews.com - March 8 at 7:06 PM
Abaxis Inc (ABAX) COO Sells $689,900.00 in StockAbaxis Inc (ABAX) COO Sells $689,900.00 in Stock
www.americanbankingnews.com - March 8 at 6:29 PM
Abaxis Banks on Strong Veterinary Business Amid Margin WoesAbaxis Banks on Strong Veterinary Business Amid Margin Woes
finance.yahoo.com - March 6 at 4:52 PM
Factors of Influence in 2018, Key Indicators and Opportunity within Cypress Semiconductor, Abaxis,Inc, Universal Health Services, CASI Pharmaceuticals, Energy Transfer Partners, and Arconic — New Research Emphasizes Economic GrowthFactors of Influence in 2018, Key Indicators and Opportunity within Cypress Semiconductor, Abaxis,Inc, Universal Health Services, CASI Pharmaceuticals, Energy Transfer Partners, and Arconic — New Research Emphasizes Economic Growth
finance.yahoo.com - March 5 at 9:35 AM
Eaton Vance Management Sells 1,349 Shares of Abaxis Inc (ABAX)Eaton Vance Management Sells 1,349 Shares of Abaxis Inc (ABAX)
www.americanbankingnews.com - March 4 at 12:24 PM
Quidel (QDEL) & Abaxis (ABAX) Head-To-Head ContrastQuidel (QDEL) & Abaxis (ABAX) Head-To-Head Contrast
www.americanbankingnews.com - March 3 at 5:16 PM
Abaxis Inc (ABAX) Insider Achim Henkel Sells 3,600 SharesAbaxis Inc (ABAX) Insider Achim Henkel Sells 3,600 Shares
www.americanbankingnews.com - March 1 at 3:22 PM
An Insight into Abaxis’s Business SegmentsAn Insight into Abaxis’s Business Segments
finance.yahoo.com - March 1 at 9:06 AM
Exploring Abaxis’s Financial PerformanceExploring Abaxis’s Financial Performance
finance.yahoo.com - March 1 at 9:06 AM
Abaxis Inc (ABAX) Expected to Post Quarterly Sales of $66.23 MillionAbaxis Inc (ABAX) Expected to Post Quarterly Sales of $66.23 Million
www.americanbankingnews.com - February 27 at 8:06 AM
Why Is Abaxis (ABAX) Up 6.5% Since Its Last Earnings Report?Why Is Abaxis (ABAX) Up 6.5% Since Its Last Earnings Report?
finance.yahoo.com - February 26 at 9:17 AM
Abaxis Inc (ABAX) Shares Sold by Comerica BankAbaxis Inc (ABAX) Shares Sold by Comerica Bank
www.americanbankingnews.com - February 26 at 6:10 AM
Pinebridge Investments L.P. Has $1.45 Million Stake in Abaxis Inc (ABAX)Pinebridge Investments L.P. Has $1.45 Million Stake in Abaxis Inc (ABAX)
www.americanbankingnews.com - February 25 at 9:30 AM
Abaxis Inc (ABAX) Expected to Post Earnings of $0.32 Per ShareAbaxis Inc (ABAX) Expected to Post Earnings of $0.32 Per Share
www.americanbankingnews.com - February 25 at 8:30 AM
Abaxis, Inc. to Present at the Bank of America Merrill Lynch Animal Health Summit and the Raymond James 39th Annual Institutional Investors ConferenceAbaxis, Inc. to Present at the Bank of America Merrill Lynch Animal Health Summit and the Raymond James 39th Annual Institutional Investors Conference
finance.yahoo.com - February 22 at 9:14 AM
Abaxis Inc (ABAX) Given Consensus Rating of "Hold" by AnalystsAbaxis Inc (ABAX) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - February 20 at 9:34 PM
Critical Comparison: Abaxis (ABAX) & Invivo Therapeutics (NVIV)Critical Comparison: Abaxis (ABAX) & Invivo Therapeutics (NVIV)
www.americanbankingnews.com - February 19 at 1:20 PM
Cytosorbents (CTSO) and Abaxis (ABAX) Critical AnalysisCytosorbents (CTSO) and Abaxis (ABAX) Critical Analysis
www.americanbankingnews.com - February 15 at 3:18 AM
Abaxis Inc (ABAX) Expected to Announce Quarterly Sales of $66.23 MillionAbaxis Inc (ABAX) Expected to Announce Quarterly Sales of $66.23 Million
www.americanbankingnews.com - February 10 at 6:34 AM

SEC Filings

Abaxis (NASDAQ:ABAX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Abaxis (NASDAQ:ABAX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Abaxis (NASDAQ ABAX) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.